Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006, 355 (3): 260-269. 10.1056/NEJMoa051530.
Article
CAS
PubMed
Google Scholar
Owan TE, Redfield MM: Epidemiology of diastolic heart failure. Prog Cardiovasc Dis. 2005, 47 (5): 320-332. 10.1016/j.pcad.2005.02.010.
Article
PubMed
Google Scholar
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006, 355 (3): 251-259. 10.1056/NEJMoa052256.
Article
CAS
PubMed
Google Scholar
Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. Jama. 2003, 289 (2): 194-202. 10.1001/jama.289.2.194.
Article
PubMed
Google Scholar
Paulus WJ, van Ballegoij JJ: Treatment of heart failure with normal ejection fraction: an inconvenient truth!. J Am Coll Cardiol. 55 (6): 526-537.
Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R: Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007, 28 (9): 1128-1134. 10.1093/eurheartj/ehm102.
Article
PubMed
Google Scholar
Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003, 107 (9): 1278-1283. 10.1161/01.CIR.0000054164.99881.00.
Article
CAS
PubMed
Google Scholar
Braunwald E: Biomarkers in heart failure. N Engl J Med. 2008, 358 (20): 2148-2159. 10.1056/NEJMra0800239.
Article
CAS
PubMed
Google Scholar
Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, et al: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005, 112 (12): e154-235. 10.1161/CIRCULATIONAHA.105.167586.
Article
PubMed
Google Scholar
Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, et al: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007, 28 (20): 2539-2550. 10.1093/eurheartj/ehm037.
Article
PubMed
Google Scholar
Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM: Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem. 2008, 54 (4): 723-728. 10.1373/clinchem.2007.097162.
Article
CAS
PubMed
Google Scholar
Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA: Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 56 (2): 254-261.
Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, Angelici L, Barlera S, Parrinello G, Maggioni AP, et al: Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007, 116 (11): 1242-1249. 10.1161/CIRCULATIONAHA.106.655076.
Article
CAS
PubMed
Google Scholar
Kawahara C, Tsutamoto T, Nishiyama K, Yamaji M, Sakai H, Fujii M, Yamamoto T, Horie M: Prognostic Role of High-Sensitivity Cardiac Troponin T in Patients With Nonischemic Dilated Cardiomyopathy. Circ J.
Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O'Connor CM, Felker GM: Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 56 (14): 1071-1078.
Niizeki T, Takeishi Y, Arimoto T, Nozaki N, Hirono O, Watanabe T, Nitobe J, Miyashita T, Miyamoto T, Koyama Y, et al: Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure. Circ J. 2008, 72 (1): 109-114. 10.1253/circj.72.109.
Article
CAS
PubMed
Google Scholar
Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, Watanabe T, Nitobe J, Harada M, Suzuki S, et al: Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail. 2007, 13 (2): 120-127. 10.1016/j.cardfail.2006.10.014.
Article
CAS
PubMed
Google Scholar
Niizeki T, Takeishi Y, Arimoto T, Takahashi T, Okuyama H, Takabatake N, Nozaki N, Hirono O, Tsunoda Y, Shishido T, et al: Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure. Circ J. 2005, 69 (8): 922-927. 10.1253/circj.69.922.
Article
CAS
PubMed
Google Scholar
Futh R, Dinh W, Bansemir L, Ziegler G, Bufe A, Wolfertz J, Scheffold T, Lankisch M: Newly detected glucose disturbance is associated with a high prevalence of diastolic dysfunction: double risk for the development of heart failure?. Acta Diabetol. 2009, 46 (4): 335-338. 10.1007/s00592-009-0105-8.
Article
CAS
PubMed
Google Scholar
Stahrenberg R, Edelmann F, Mende M, Kockskamper A, Dungen HD, Scherer M, Kochen MM, Binder L, Herrmann-Lingen C, Gelbrich G, et al: Association of glucose metabolism with diastolic function along the diabetic continuum. Diabetologia. 53 (7): 1331-1340.
Hallen J, Johansen OE, Birkeland KI, Gullestad L, Aakhus S, Endresen K, Tjora S, Jaffe AS, Atar D: Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus. Cardiovasc Diabetol. 9: 52-
Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, Giani G: High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003, 46 (2): 182-189.
CAS
PubMed
Google Scholar
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18 (12): 1440-1463. 10.1016/j.echo.2005.10.005.
Article
PubMed
Google Scholar
Ishino M, Takeishi Y, Niizeki T, Watanabe T, Nitobe J, Miyamoto T, Miyashita T, Kitahara T, Suzuki S, Sasaki T, et al: Risk stratification of chronic heart failure patients by multiple biomarkers: implications of BNP, H-FABP, and PTX3. Circ J. 2008, 72 (11): 1800-1805. 10.1253/circj.CJ-08-0157.
Article
CAS
PubMed
Google Scholar
Horwich TB, Patel J, MacLellan WR, Fonarow GC: Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation. 2003, 108 (7): 833-838. 10.1161/01.CIR.0000084543.79097.34.
Article
CAS
PubMed
Google Scholar
Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H, Kataoka K, Ito H, Matsumori A, Sasayama S, et al: Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation. 2001, 103 (3): 369-374.
Article
CAS
PubMed
Google Scholar
de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, et al: Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA. 304 (22): 2503-2512.
deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL: Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 304 (22): 2494-2502.
Sundstrom J, Ingelsson E, Berglund L, Zethelius B, Lind L, Venge P, Arnlov J: Cardiac troponin-I and risk of heart failure: a community-based cohort study. Eur Heart J. 2009, 30 (7): 773-781.
Article
PubMed
Google Scholar
Schaap FG, van der Vusse GJ, Glatz JF: Fatty acid-binding proteins in the heart. Mol Cell Biochem. 1998, 180 (1-2): 43-51.
Article
CAS
PubMed
Google Scholar
Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y, Takano T: Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med. 2002, 113 (9): 717-722. 10.1016/S0002-9343(02)01394-3.
Article
CAS
PubMed
Google Scholar
Arimoto T, Takeishi Y, Shiga R, Fukui A, Tachibana H, Nozaki N, Hirono O, Nitobe J, Miyamoto T, Hoit BD, et al: Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail. 2005, 11 (1): 56-60. 10.1016/j.cardfail.2004.03.005.
Article
CAS
PubMed
Google Scholar
Sugiura T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y: Circulating levels of myocardial proteins predict future deterioration of congestive heart failure. J Card Fail. 2005, 11 (7): 504-509. 10.1016/j.cardfail.2005.04.025.
Article
CAS
PubMed
Google Scholar
Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W: Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol. 1991, 67 (16): 1360-1367. 10.1016/0002-9149(91)90466-X.
Article
CAS
PubMed
Google Scholar
Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR, Pitzus AE, Garcia EH, Obregon R, Brizuela M, et al: Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation. 2004, 110 (16): 2376-2382. 10.1161/01.CIR.0000145158.33801.F3.
Article
PubMed
Google Scholar
Hessel MH, Atsma DE, van der Valk EJ, Bax WH, Schalij MJ, van der Laarse A: Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch. 2008, 455 (6): 979-986. 10.1007/s00424-007-0354-8.
Article
CAS
PubMed
Google Scholar
Taniguchi R, Sato Y, Yamada T, Ooba M, Higuchi H, Matsumori A, Kimura T, Kita T: Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Circ J. 2004, 68 (12): 1160-1164. 10.1253/circj.68.1160.
Article
CAS
PubMed
Google Scholar
Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr. 2009, 10 (2): 165-193.
Article
PubMed
Google Scholar
Chomsky DB, Lang CC, Rayos GH, Shyr Y, Yeoh TK, Pierson RN, Davis SF, Wilson JR: Hemodynamic exercise testing. A valuable tool in the selection of cardiac transplantation candidates. Circulation. 1996, 94 (12): 3176-3183.
Article
CAS
PubMed
Google Scholar